Kardiovaskularni faktori rizika, kardiovaskularne bolesti i COVID-19: krovni pregled sistematskih pregleda.
European heart journal. Quality of care & clinical outcomes
Sažetak istraživanja
Ciljevi Objediniti dokaze za utvrđivanje (i) povezanosti između kardiovaskularnih faktora rizika i zdravstvenih ishoda s koronavirusom 2019 (COVID-19); i (ii) uticaj COVID-19 na zdravlje kardiovaskularnog sistema.
Metode i rezultati Sproveden je krovni pregled sistematskih pregleda. Od 1. januara 2020. do 5. novembra 2020. pretraženo je četrnaest medicinskih baza podataka i servera za pre-štampanje. Pregled se fokusirao na recenzije ocijenjene kao umjerene ili visokokvalitetne pomoću AMSTAR 2 alata. Identificirane su 84 revizije; 31 recenzija ocijenjena je kao umjerena kvaliteta, a jedna je bila visokog kvaliteta. Sljedeći faktori rizika bili su povezani sa većom smrtnošću i teškim COVID-19: bubrežna bolest [odnos šanse (OR) (95% interval pouzdanosti) za mortalitet 3,07 (2,43-3,88)], dijabetes melitus [OR 2,09 (1,80-2,42)], hipertenzija (OR 2.42)], hipertenzija (OR 2.102). omjer (RR) 1,26 (1,20-1,32)], cerebrovaskularne bolesti [RR 2,75 (1,54-4,89)] i kardiovaskularne bolesti [OR 2,65 (1,86-3,78)]. Bolest jetre bila je povezana s većim izgledima smrtnosti [OR 2,81 (1,31-6,01)], ali ne i sa teškim COVID-19. Trenutno pušenje je povezano s većim rizikom od teškog COVID-19 [RR 1,80 (1,14-2,85)], ali ne i smrtnost. Gojaznost povezana s većim izgledima smrtnosti [OR 2,18 (1,10-4,34)], ali nije bilo dokaza za teški oblik COVID-19. Kod pacijenata hospitaliziranih s COVID-19, identificirane su sljedeće kardiovaskularne komplikacije: akutna srčana insuficijencija (2%), infarkt miokarda (4%), duboka venska tromboza (7%), ozljeda miokarda (10%), angina (10%), aritmije (18%), plućna embolija 2%) i venbolna embolija (5%).
Zaključak Mnogi od faktora rizika koji su identificirani kao povezani sa negativnim ishodima s COVID-19 potencijalno se mogu mijenjati. Strategije primarne i sekundarne prevencije koje su usmjerene na kardiovaskularne faktore rizika mogu poboljšati ishode za ljude nakon COVID-19.
Prikaži originalni naslov i sažetak na engleskom
Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews.
Aims To consolidate evidence to determine (i) the association between cardiovascular risk factors and health outcomes with coronavirus 2019 (COVID-19); and (ii) the impact of COVID-19 on cardiovascular health.
Methods and results An umbrella review of systematic reviews was conducted. Fourteen medical databases and pre-print servers were searched from 1 January 2020 to 5 November 2020. The review focused on reviews rated as moderate or high-quality using the AMSTAR 2 tool. Eighty-four reviews were identified; 31 reviews were assessed as moderate quality and one was high-quality. The following risk factors were associated with higher mortality and severe COVID-19: renal disease [odds ratio (OR) (95% confidence interval) for mortality 3.07 (2.43-3.88)], diabetes mellitus [OR 2.09 (1.80-2.42)], hypertension [OR 2.50 (2.02-3.11)], smoking history [risk ratio (RR) 1.26 (1.20-1.32)], cerebrovascular disease [RR 2.75 (1.54-4.89)], and cardiovascular disease [OR 2.65 (1.86-3.78)]. Liver disease was associated with higher odds of mortality [OR 2.81 (1.31-6.01)], but not severe COVID-19. Current smoking was associated with a higher risk of severe COVID-19 [RR 1.80 (1.14-2.85)], but not mortality. Obesity associated with higher odds of mortality [OR 2.18 (1.10-4.34)], but there was an absence of evidence for severe COVID-19. In patients hospitalized with COVID-19, the following incident cardiovascular complications were identified: acute heart failure (2%), myocardial infarction (4%), deep vein thrombosis (7%), myocardial injury (10%), angina (10%), arrhythmias (18%), pulmonary embolism (19%), and venous thromboembolism (25%).
Conclusion Many of the risk factors identified as associated with adverse outcomes with COVID-19 are potentially modifiable. Primary and secondary prevention strategies that target cardiovascular risk factors may improve outcomes for people following COVID-19.
Izvorni podaci
- DOI
- 10.1093/ehjqcco/qcab029
- PMID
- 34107535
- PMCID
- PMC8294691
- Provjereno
- 2026-07-26
Naslov i sažetak prevedeni su automatski i prijevod može sadržavati netačnosti ili neprecizne stručne izraze. Za sve detalje, citiranje i medicinsko tumačenje pregledajte originalnu englesku verziju članka. Ne donosite zdravstvene odluke samo na osnovu ovog prijevoda.
Pregledaj originalni članak na engleskom